Troy H. Guthrie

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.5K citations · Full text

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

Jedd D. Wolchok, Bart Neyns, Gerald P. Linette et al. · The Lancet Oncology · 2009 · 1.2K citations

Pretreated Advanced Melanoma, Medicine, Melanoma +8

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 851 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +9

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 837 citations · Full text

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Nasser H. Hanna, Paul A. Bunn, Corey J. Langer et al. · Journal of Clinical Oncology · 2006 · 673 citations · Full text